XML 49 R37.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statement of Operations (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Mar. 31, 2023
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Jun. 30, 2023
Operating expenses                
General and administrative $ 3,229,202 $ 4,416,716 $ 3,053,998 $ 3,538,541 $ 7,470,713 $ 10,699,915 $ 9,445,776 $ 12,848,131
Research and development 3,954,744 3,569,167 3,613,852 1,509,085 7,183,018 11,137,762 3,464,372 7,565,735
Exploration costs 1,422,758 823,425 1,349,920 584,344 2,173,345 3,596,103 1,479,507 2,014,341
Total operating expenses 8,606,704 8,809,307 8,017,769 5,631,970 16,827,076 25,433,780 14,389,655 22,428,207
Net loss before other income (expense) $ (8,606,704) $ (8,809,307) (8,017,769) $ (5,631,970) (16,827,076) $ (25,433,780) $ (14,389,655) (22,428,207)
Net loss attributable to common stockholders     $ (8,891,977)   $ (19,069,836)     $ (22,191,140)
Net loss per share, basic $ (0.19) $ (0.21) $ (0.19) $ (0.13) $ (0.40) $ (0.59) $ (0.33) $ (0.51)
Net loss per share, diluted $ (0.19) $ (0.21) $ (0.19) $ (0.13) $ (0.40) $ (0.59) $ (0.33) $ (0.51)
Other income (expense)                
Amortization of financing costs     $ (732,896)          
Total other income (expense) $ (1,388,433) $ (1,368,552) (874,208) $ 23,949 $ (2,242,760) $ (3,631,193) $ 150,210  
Amortization and accretion of financing costs (1,150,127) (1,132,258)   (1,865,154) (3,015,280)  
Change in fair value of derivative liability (216,765) (229,473)   (229,473) (446,238)  
Net loss $ (9,995,137) (10,177,859)   $ (5,608,021) (19,069,836) $ (29,064,973) $ (14,239,445)  
Previously Reported [Member]                
Operating expenses                
General and administrative   4,310,452 2,948,846   7,259,298     $ 11,960,831
Research and development   3,148,873 2,155,314   5,304,187     7,703,895
Exploration costs   771,523 1,279,782   2,051,305     1,910,548
Total operating expenses   8,230,848 6,383,942   14,614,790     21,575,274
Net loss before other income (expense)   $ (8,230,848) (6,383,942)   (14,614,790)     (21,575,274)
Net loss attributable to common stockholders     $ (7,231,985)   $ (16,523,420)     $ (21,338,207)
Net loss per share, basic   $ (0.19) $ (0.16)   $ (0.35)     $ (0.49)
Net loss per share, diluted   $ (0.19) $ (0.16)   $ (0.35)     $ (0.49)
Other income (expense)                
Amortization of financing costs     $ (706,731)          
Total other income (expense)   $ (1,060,587) (848,043)   $ (1,908,630)      
Amortization and accretion of financing costs   (1,053,766)     (1,760,497)      
Change in fair value of derivative liability            
Net loss   (9,291,435)     (16,523,420)      
Revision of Prior Period, Error Correction, Adjustment [Member]                
Operating expenses                
General and administrative   106,264 105,152   211,415     $ 887,300
Research and development   420,294 1,458,538   1,878,831     (138,160)
Exploration costs   51,902 70,138   122,040     103,793
Total operating expenses   578,459 1,633,827   2,212,286     852,933
Net loss before other income (expense)   $ (578,459) (1,633,827)   (2,212,286)     (852,933)
Net loss attributable to common stockholders     $ (1,659,992)   $ (2,546,416)     $ (852,933)
Net loss per share, basic   $ (0.02) $ (0.03)   $ (0.05)     $ (0.02)
Net loss per share, diluted   $ (0.02) $ (0.03)   $ (0.05)     $ (0.02)
Other income (expense)                
Amortization of financing costs     $ (26,165)          
Total other income (expense)   $ (307,965) $ (26,165)   $ (334,130)      
Amortization and accretion of financing costs   (78,492)     (104,657)      
Change in fair value of derivative liability   (229,473)     (229,473)      
Net loss   $ (886,424)     $ (2,546,416)